Skip to content
MedsAcross

Medicine

Aripiprazole 2 mg tablet

Aripiprazole · Oral
Available on requestPrescription onlyUS FDAGeneric name

Aripiprazole 2 mg tablet is a generic prescription medicine for oral use, made by 29 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20º to 25º C (68º to 77ºF).

Key facts

Active ingredient (INN)
Aripiprazole
Brand
Sold under the generic name
Strength
2 mg
Dosage form
Tablet
Route
Oral
Packs
100 tablets, 30 tablets, 180 tablets and 106 more
Manufacturers
Alembic PharmaceuticalsIndiaCamber PharmaceuticalsIndiaAscend LaboratoriesIndiaAurobindo PharmaIndiaDr. Reddy's LaboratoriesIndiaMacleods PharmaceuticalsIndiaAccord HealthcareIndiaAjanta PharmaIndiaTorrent PharmaceuticalsIndia29 labelers on the register
Origin register
US FDA, United States
Storage
Store at 20º to 25º C (68º to 77ºF).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
N05AX12 Aripiprazole
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
28 April 2015
Identifiers
RxCUI 349490, 349545, 349547 +3DailyMed set ID b284b294-40a0-4ccd-b7b7-b61267cd4e76, 0a6fa113-6bb2-4f88-af07-ce0914c98ff2, abb8ad7e-7998-4485-a09f-a2892190f4ad +37NDC 72865-153, 72865-180, 43547-884 +37Application ANDA205064, ANDA205363, ANDA204838 +9

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

A sample of 40 packs from 29 labelers. The register lists 109 packs for this generic presentation, and we confirm the exact pack on the quote.

PackCodeLabelerMarketed since
100 tablet in 1 carton46708-254-10Alembic PharmaceuticalsIndia28 April 2015
30 tablet in 1 bottle46708-254-30Alembic PharmaceuticalsIndia28 April 2015
100 tablet in 1 bottle46708-254-31Alembic PharmaceuticalsIndia28 April 2015
180 tablet in 1 bottle46708-254-45Alembic PharmaceuticalsIndia28 April 2015
60 tablet in 1 bottle46708-254-60Alembic PharmaceuticalsIndia28 April 2015
500 tablet in 1 bottle46708-254-71Alembic PharmaceuticalsIndia28 April 2015
1000 tablet in 1 bottle46708-254-91Alembic PharmaceuticalsIndia28 April 2015
100 tablet in 1 carton62332-097-10Alembic PharmaceuticalsIndia7 July 2016
30 tablet in 1 bottle62332-097-30Alembic PharmaceuticalsIndia7 July 2016
100 tablet in 1 bottle62332-097-31Alembic PharmaceuticalsIndia7 July 2016
500 tablet in 1 bottle62332-097-71Alembic PharmaceuticalsIndia7 July 2016
1000 tablet in 1 bottle62332-097-91Alembic PharmaceuticalsIndia7 July 2016
100 tablet in 1 bottle31722-819-01Camber PharmaceuticalsIndia28 April 2015
500 tablet in 1 bottle31722-819-05Camber PharmaceuticalsIndia2 February 2024
30 tablet in 1 bottle31722-819-30Camber PharmaceuticalsIndia28 April 2015
10 tablet in 1 blister pack31722-819-31Camber PharmaceuticalsIndia28 April 2015
250 tablet in 1 carton31722-819-32Camber PharmaceuticalsIndia28 April 2015
100 tablet in 1 bottle31722-919-01Camber PharmaceuticalsIndia8 August 2017
30 tablet in 1 bottle31722-919-30Camber PharmaceuticalsIndia8 August 2017
500 tablet in 1 bottle43598-554-05Dr. Reddy's LaboratoriesIndia29 September 2016
30 tablet in 1 bottle43598-554-30Dr. Reddy's LaboratoriesIndia29 September 2016
500 tablet in 1 bottle43598-965-05Dr. Reddy's LaboratoriesIndia16 March 2020
30 tablet in 1 bottle43598-965-30Dr. Reddy's LaboratoriesIndia16 March 2020
100 tablet in 1 bottle, plastic16729-278-01Accord HealthcareIndia15 February 2017
30 tablet in 1 bottle, plastic16729-278-10Accord HealthcareIndia15 February 2017
30 tablet in 1 bottle27241-051-03Ajanta PharmaIndia30 May 2017
500 tablet in 1 bottle27241-051-08Ajanta PharmaIndia30 May 2017
100 tablet in 1 bottle67877-430-01Ascend LaboratoriesIndia27 February 2019
30 tablet in 1 bottle67877-430-03Ascend LaboratoriesIndia27 February 2019
500 tablet in 1 bottle67877-430-05Ascend LaboratoriesIndia27 February 2019
1 blister pack in 1 carton / 7 tablet in 1 blister pack67877-430-32Ascend LaboratoriesIndia27 February 2019
10 blister pack in 1 carton / 10 tablet in 1 blister pack67877-430-38Ascend LaboratoriesIndia27 February 2019
100 tablet in 1 bottle65862-661-01Aurobindo PharmaIndia8 October 2015
500 tablet in 1 bottle65862-661-05Aurobindo PharmaIndia8 October 2015
30 tablet in 1 bottle65862-661-30Aurobindo PharmaIndia8 October 2015
10 blister pack in 1 carton / 10 tablet in 1 blister pack65862-661-78Aurobindo PharmaIndia8 October 2015
30 tablet in 1 bottle33342-122-07Macleods PharmaceuticalsIndia8 October 2016
100 tablet in 1 bottle33342-122-11Macleods PharmaceuticalsIndia8 October 2016
10 blister pack in 1 carton / 10 tablet in 1 blister pack33342-122-12Macleods PharmaceuticalsIndia8 October 2016
100 tablet in 1 bottle13668-216-01Torrent PharmaceuticalsIndia28 April 2015

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 15 November 2002Drugs@FDA
EU (EMA)AuthorisedEMA medicines data
India (CDSCO)Not yet confirmed against CDSCO approval lists—
AustriaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
BelgiumRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
BulgariaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CroatiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CyprusRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CzechiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
DenmarkRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
EstoniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
FinlandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
FranceRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
GermanyRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
GreeceRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
HungaryRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
IcelandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
IrelandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
ItalyRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LatviaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LiechtensteinRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LithuaniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LuxembourgRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
MaltaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
NetherlandsRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
NorwayRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
PolandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
PortugalRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
RomaniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SlovakiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SloveniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SpainRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SwedenRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Aripiprazole 2 mg tablet.

Compare 1

Other strengths and forms of Aripiprazole

Clinical summary

Aripiprazole is an atypical antipsychotic. It is available as tablets, orally disintegrating tablets and oral solution for intramuscular use. MedsAcross supplies Aripiprazole for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Aripiprazole

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Aripiprazole 2 mg tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.